查看完整行情页>>

|

货币单位:美元(USD)

拜耳集团

Bayer AG (bayry)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Rodrigo Santos Rodrigo Santos is currently the President of the Crop Science Division at Bayer AG. He has an MBA from The Ohio University and an undergraduate degree from Escola Superior de Agricultura Luiz de Queiroz.
Norbert Winkeljohann Norbert Winkeljohann is currently the Deputy Chairman-Supervisory Board at Deutsche Bank AG since 2022 and the Chairman-Supervisory Board at Bayer AG since 2020. He is also the Chairman-Supervisory Board at Sievert SE, Bohnenkamp AG, and the Co-Managing Director at Sievert Baustoffe GmbH & Co. KG. Additionally, he serves as a Member-Supervisory Board at Georgsmarienhütte Holding GmbH. In his former positions, Dr. Winkeljohann was the Co-Chairman-Supervisory Board at heristo AG from 2018 to 2021. He also held the role of Chairman-Management Board at PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft from 2010 to 2018 and at Pwc Europe SE. Wirtschaftspruefungsgesellschaft from 2011 to 2018. Prior to that, he was the Head-Mid-Caps & Family Firms Business Division at PricewaterhouseCoopers AG Wirtschaftsprüfungsgesellschaft from 1999 to 2010. He started his career as an Auditor & Executive Partner at Societâts Treuhand GmbH from 1994 to 1998. He was also a Member-Network Leadership Team at PricewaterhouseCoopers International Ltd. from 2010 to 2018. Dr. Winkeljohann obtained an MBA from the University of Münster in 1983 and a doctorate from the University of Hagen in 1986.
Bijoy Sagar Bijoy Sagar is currently the Director at AI Lean, Inc. and the Chief Information Technology Officer at Bayer AG. Previously, he held positions as the Chief Digital Technology Officer & Vice President at Stryker Corp., the Global Head-Information Systems at Merck KGaA, and the Chief Information Officer at Merck Millipore Corp. He received his undergraduate and graduate degrees from the University of Mumbai.
Wolfgang U. Nickl Wolfgang U. Nickl is currently the Head-Finance at Bayer AG since 2018. Prior to his current position, he served as the Chief Financial Officer & Executive Vice President at ASML Holding NV from 2013 to 2018 and at Western Digital Corp. from 2012 to 2013. He also held the position of Chief Financial Officer at PCG Trading LLC. Mr. Nickl obtained an MBA from USC Marshall School of Business in 2005 and an undergraduate degree from Duale Hochschule Baden-Württemberg Villingen-Schwenningen in 1992.
William N. Anderson William N. Anderson is currently the Chief Executive Officer at Bayer AG since 2023. He is also currently serving as a Director at Chugai Pharmaceutical Co., Ltd. since 2019 and as a Director at Pharmaceutical Research & Manufacturers of America. Previously, he held the position of Chief Executive Officer & Director at Genentech, Inc. and was the Chief Executive Officer at Roche Pharmaceuticals, Inc. from 2019 to 2022.
Christian Rommel Christian Rommel is currently a Director at Asklepios BioPharmaceutical, Inc., Vividion Therapeutics, Inc., CRISPR Therapeutics AG, and Bayer AG. He previously worked as a Senior Scientist at Regeneron Pharmaceuticals, Inc., SVP and Head of Oncology Research & Early Development at F. Hoffmann-La Roche Ltd., Chief Scientific Officer at Intellikine LLC, and Head of Target Research at Merck Serono Ltd. He holds a doctorate degree from the Max-Planck-Institute for Molecular Genetics and an undergraduate degree from the University of Greifswald.
Philipp Blank Philipp Blank currently works at Bayer AG, as Head-Law, Compliance & Information Technology.
Stefan Oelrich Stefan Oelrich is currently a Director at Vividion Therapeutics, Inc. and a President-Pharmaceuticals Division at Bayer AG. He is also a Member-Management Board at American Chamber of Commerce in Germany eV, an Advisor at Longwood Fund Management LLC, and a Member-Supervisory Board at Berlin Institute of Health. Previously, he worked as an Executive VP-Diabetes & Cardiovascular at Sanofi from 2011 to 2018.
Heiko Willem-Jan Schipper Heiko Willem-Jan Schipper currently works at Nestlé Nutrition, as Chief Executive Officer from 2014, Bayer AG, as President-Consumer Health Division, and Koninklijke FrieslandCampina NV, as Member-Supervisory Board from 2019. Mr. Schipper also formerly worked at Glycom A, as Director. Mr. Schipper received his graduate degree from Erasmus University Rotterdam.